LUCD Annual Cash & Cash Equivalents
$18.90 M
-$3.58 M-15.92%
31 December 2023
Summary:
As of January 23, 2025, LUCD annual cash & cash equivalents is $18.90 million, with the most recent change of -$3.58 million (-15.92%) on December 31, 2023. During the last 3 years, it has risen by +$18.79 million (+16923.42%). LUCD annual cash & cash equivalents is now -64.78% below its all-time high of $53.66 million, reached on December 31, 2021.LUCD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUCD Quarterly Cash And Cash Equivalents
$14.49 M
-$10.43 M-41.86%
30 September 2024
Summary:
As of January 23, 2025, LUCD quarterly cash and cash equivalents is $14.49 million, with the most recent change of -$10.43 million (-41.86%) on September 30, 2024. Over the past year, it has dropped by -$9.56 million (-39.75%). LUCD quarterly cash and cash equivalents is now -73.00% below its all-time high of $53.66 million, reached on December 31, 2021.LUCD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUCD Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.9% | -39.8% |
| 3 y3 years | +10000.0% | -39.8% |
| 5 y5 years | +10000.0% | -39.8% |
LUCD Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.8% | at low | -73.0% | at low |
| 5 y | 5-year | -64.8% | >+9999.0% | -73.0% | >+9999.0% |
| alltime | all time | -64.8% | >+9999.0% | -73.0% | >+9999.0% |
Lucid Diagnostics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.49 M(-41.9%) |
| June 2024 | - | $24.92 M(+0.6%) |
| Mar 2024 | - | $24.77 M(+31.1%) |
| Dec 2023 | $18.90 M(-15.9%) | $18.90 M(-21.4%) |
| Sept 2023 | - | $24.05 M(-26.2%) |
| June 2023 | - | $32.57 M(-17.6%) |
| Mar 2023 | - | $39.52 M(+75.9%) |
| Dec 2022 | $22.47 M | $22.47 M(-16.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $26.93 M(-17.6%) |
| June 2022 | - | $32.68 M(-31.8%) |
| Mar 2022 | - | $47.92 M(-10.7%) |
| Dec 2021 | $53.66 M(>+9900.0%) | $53.66 M(>+9900.0%) |
| Sept 2021 | - | $21.30 K(-99.0%) |
| June 2021 | - | $2.23 M(+1910.1%) |
| Dec 2020 | $111.00 K(-29.0%) | $111.00 K |
| Dec 2019 | $156.40 K | - |
FAQ
- What is Lucid Diagnostics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Lucid Diagnostics?
- What is Lucid Diagnostics annual cash & cash equivalents year-on-year change?
- What is Lucid Diagnostics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Lucid Diagnostics?
- What is Lucid Diagnostics quarterly cash and cash equivalents year-on-year change?
What is Lucid Diagnostics annual cash & cash equivalents?
The current annual cash & cash equivalents of LUCD is $18.90 M
What is the all time high annual cash & cash equivalents for Lucid Diagnostics?
Lucid Diagnostics all-time high annual cash & cash equivalents is $53.66 M
What is Lucid Diagnostics annual cash & cash equivalents year-on-year change?
Over the past year, LUCD annual cash & cash equivalents has changed by -$3.58 M (-15.92%)
What is Lucid Diagnostics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LUCD is $14.49 M
What is the all time high quarterly cash and cash equivalents for Lucid Diagnostics?
Lucid Diagnostics all-time high quarterly cash and cash equivalents is $53.66 M
What is Lucid Diagnostics quarterly cash and cash equivalents year-on-year change?
Over the past year, LUCD quarterly cash and cash equivalents has changed by -$9.56 M (-39.75%)